|
Delayed
NSE India S.E.
07:48:00 17/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 2,617.20 INR | -0.60% |
|
-2.25% | +28.58% |
| 11-09 | Acucort signs exclusive agreement for Zeqmelit in Canada - launch expected in 2028 | FW |
| 11-06 | Glenmark Pharmaceuticals Limited, Q2 2027 Earnings Call, Nov 06, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.60% | -2.25% | +18.40% | +12.36% | +28.58% | +40.02% | +237.25% | +421.92% | +196.05% | 7.91B | ||
| -0.82% | +1.40% | +13.89% | +21.31% | +33.22% | +39.64% | +143.17% | +455.51% | +1,760.76% | 1,275B | ||
| -1.12% | +0.16% | +10.56% | +8.53% | +36.53% | +44.21% | +88.24% | +73.70% | +142.82% | 680B | ||
| -0.16% | +0.43% | +3.20% | +18.08% | +28.91% | +26.76% | +113.01% | +153.01% | +378.63% | 521B | ||
| -0.15% | +2.04% | +7.94% | +15.26% | +24.71% | +43.06% | +72.81% | +10.88% | +76.19% | 389B | ||
| -2.23% | -2.89% | -1.02% | +6.35% | +37.24% | +55.47% | +41.64% | +71.75% | +130.66% | 356B | ||
| -0.46% | +1.72% | +8.87% | +10.88% | +23.87% | +30.01% | +63.11% | +77.46% | +88.03% | 305B | ||
| -0.62% | -0.23% | +12.76% | +22.46% | +1.77% | +3.71% | +38.05% | +63.15% | +222.36% | 287B | ||
| -0.72% | -0.63% | +6.90% | +11.35% | +41.25% | +37.29% | +71.87% | +125.09% | +214.01% | 250B | ||
| -0.30% | -1.03% | +7.29% | +21.12% | +36.53% | +34.04% | +124.88% | +150.53% | +120.50% | 208B | ||
| -0.90% | +4.56% | +9.88% | -3.21% | -12.30% | -8.29% | -57.95% | -24.04% | +147.18% | 185B | ||
| -0.10% | -1.27% | -2.43% | +7.73% | +15.90% | +15.16% | -3.06% | -41.81% | -9.70% | 164B | ||
| -0.15% | -2.37% | +7.61% | +6.34% | +18.62% | +23.02% | +56.79% | +185.56% | +494.44% | 136B | ||
| -0.79% | +1.27% | +5.32% | -1.41% | +16.67% | +34.90% | +23.78% | +6.48% | +11.98% | 129B | ||
| +0.20% | +4.31% | +9.97% | +27.16% | +34.71% | +31.23% | +145.14% | +400.90% | +681.06% | 128B | ||
| -0.48% | +2.39% | +23.93% | +14.79% | +6.38% | -2.10% | +2.46% | -2.87% | +13.95% | 116B | ||
| -0.82% | +1.31% | +3.60% | +6.16% | +5.76% | +8.16% | +39.62% | -0.92% | +1.15% | 102B | ||
| -0.32% | +3.53% | +20.44% | +18.53% | +23.39% | +37.33% | +19.57% | +48.18% | +126.72% | 95.57B | ||
| -3.63% | -19.97% | -1.26% | +239.97% | +629.98% | +769.08% | +181.21% | -8.11% | - | 87.1B | ||
| -0.54% | +2.49% | +15.88% | +6.93% | -10.95% | -13.68% | +49.70% | +76.82% | +562.26% | 76.08B | ||
| Average | -0.74% | -0.01% | +9.09% | +23.53% | +51.04% | +62.45% | +72.56% | +112.16% | +282.06% | 275B | |
| Weighted average by Cap. | -0.76% | +0.63% | +9.03% | +17.83% | +36.03% | +43.77% | +84.46% | +167.92% | +558.90% |
- Stock Market
- Stocks
- GLENMARK Stock
- Sector Glenmark Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
















